Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

Merrimack Pharmaceuticals (MACK) Insider Trading & Ownership

Merrimack Pharmaceuticals (NASDAQ:MACK) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
30.57%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$2.58 M
Number Of
Insiders Selling
(Last 12 Months)
0
Get MACK Insider Trade Alerts

Want to know when executives and insiders are buying or selling Merrimack Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

MACK Insider Buying and Selling by Quarter

Merrimack Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/28/2023Eric AndersenDirectorBuy857$13.35$11,440.95  
12/26/2023Eric AndersenDirectorBuy48,693$13.15$640,312.95  
12/7/2023Eric AndersenDirectorBuy101,050$12.85$1,298,492.50  
11/17/2023Eric AndersenDirectorBuy300$12.50$3,750.00  
11/14/2023Eric AndersenDirectorBuy50,170$12.50$627,125.00  
(Data available from 1/1/2013 forward)

MACK Insider Trading Activity - Frequently Asked Questions

The list of insiders at Merrimack Pharmaceuticals includes Ana Radeljevic, Eric Andersen, Gary L Crocker, Noah G Levy, and Ulrik B Nielsen. Learn more on insiders at MACK.

30.57% of Merrimack Pharmaceuticals stock is owned by insiders. Learn more on MACK's insider holdings.

The following insiders have purchased MACK shares in the last 24 months: Ana Radeljevic ($49,996.68), Eric Andersen ($6,575,092.08), Gary L Crocker ($25,040.00), and Noah G Levy ($1,190,000.00).

Insiders have purchased a total of 648,892 MACK shares in the last 24 months for a total of $7,840,128.76 bought.



This page (NASDAQ:MACK) was last updated on 10/11/2024 by MarketBeat.com Staff
From Our Partners